Abstract Archives of the RSNA, 2011
Scientific Informal (Poster) Presentations
Presented on November 28, 2011
Participants
Sub-Events
LL-GIS-MO10A |
Noninvasive Subharmonic-aided Pressure Estimation in Patients with Suspected Portal Hypertension: Preliminary Results Flemming Forsberg PhD | Valgerdur Halldorsdottir MSC | John Eisenbrey PhD | Jaydev Dave | Jose Gonzalez MD | Cynthia Miller RN | Daniel Merton | Priscilla Machado MD | Suhyun Park PhD | Scott Dianis MSc | Carl Chalek PhD | Kai Thomenius PhD | Daniel Brown MD | Victor Navarro |
LL-GIS-MO10B |
MRI for Characterization of Primary Tumors in the Non-cirrhotic Liver: Added Value of Gd-EOB-DTPA Enhanced Hepatospecific Phase Michael Fischer MD | Olivio Donati MD | Roger Hunziker | Stefan Breitenstein | Dimitri Raptis | Michael Patak MD |
LL-GIS-MO11A |
Safety of an Intercostal Approach for Imaging-guided Percutaneous Drainage of Subdiaphragmatic Abscesses Rendon Nelson MD | Tracy Jaffe MD | Mustafa Bashir MD | Stephen Preece MD | Clare Haystead MD |
LL-GIS-MO1A |
Is 3 Tesla MRI Superior to 64-row CT in Diagnosis of Hepatocellular Carcinoma? Bettina Maiwald MMed | Donald Lobsien MD | Thomas Kahn MD | Patrick Stumpp MD, PhD |
LL-GIS-MO1B |
Assessing Necroinflammatory Activity and Fibrosis of the Liver Using Proton MR Spectroscopy in Patients with Chronic Liver Damage Haruo Watanabe MD | Satoshi Goshima MD, PhD | Hiroshi Kawada MD | Hiroshi Kondo MD | Masayuki Kanematsu MD | Kyongtae Bae MD, PhD |
LL-GIS-MO2A |
Hypovascular Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-enhanced MRI in the Cirrhotic Liver: Baseline Patient Characteristics, MRI Findings, and Tumor Growth Kinetics for Prediction of Hypervascularization Masahiro Okada MD | Yasuharu Imai | Masatoshi Kudo | Takamichi Murakami MD, PhD | Tomoko Hyodo MD | Yuki Kagawa MD | Seishi Kumano MD | Teruhito Mochizuki MD | Masatoshi Hori MD | Sachiyo Kogita |
LL-GIS-MO2B |
Diffusion-weighted MR Imaging with Navigator-triggered Prospective Acquisition Correction at 3 T for the Assessment of Hepatic Fibrosis Yasuaki Kuginuki MD | Hisao Tonami MD | Mikihiro Tsutsumi | Tomiyasu Arisawa MD |
LL-GIS-MO3A |
MR Perfusion Imaging for the Prediction of Treatment Response after Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer Joonseok Lim MD | Daehong Kim | Song-Ee Baek |
LL-GIS-MO3B |
Accuracy of Hepatic Fat Fraction Measurement Using the Multiecho Dixon Method with and without T2* Correction: Phantom and Clinical Study Norio Hayashi PhD | Osamu Matsui MD | Yasuji Ryu MD | Shigeru Sanada PhD | Masako Takanaga | Takashi Hamaguchi MS | Tosiaki Miyati PhD | Naoki Ohno MS | Yumie Takeshita | Tsuyoshi Matsuda BS | Toshinari Takamura | Hiroji Iida |
LL-GIS-MO4A |
Ultrasound for Appendicitis: Clinical and Imaging Implications of Nonvisualization of the Appendix R. Brooke Jeffrey MD | Jessica Stewart MD | Jarrett Rosenberg PhD | Eric Olcott MD |
LL-GIS-MO4B |
![]() Mohammed Azfar Siddiqui MBBS, MD | Syed Amjad Ali Rizvi | Ekram Ullah | Shagufta Wahab | Ibne Ahmad |
LL-GIS-MO5A |
Efficiency of Diffusion MRI in Detection of Colorectal Tumor Recurrences Murat Danaci | Ahmet Soyucok | Nilgun Okumus | Mehmet Nural |
LL-GIS-MO5B |
Videofluoroscopy Swallowing Study in Patients with Pharyngeal Stasis of Contrast Medium Stefano Doratiotto MD | Giovanni Morana MD | Simonetta De Giorgi MD | Massimo Pasian |
LL-GIS-MO6A |
Contrast-enhanced CT Evaluation of Hepatic Metastases in Breast Cancer Patients Undergoing Chemotherapy, Targeted Therapy, or Combination Chusilp Charnsangavej MD | Wei Yang MD | Hongying He MD, PhD | Richard Theriault DO | Marjorie Green | Mohammad Quraishi |
LL-GIS-MO6B |
The Value of 3-minute Delay Phase in Routine Oncology Follow-up MDCT for Hepatic Lesion Detection and Characterization Bettina Siewert MD | Vassilios Raptopoulos MD | Olga Brook MD | Mishal Mendiratta-Lala MD | Sofia Gourtsoyianni MD |
LL-GIS-MO7A |
The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinomas: A Retrospective Study David Liu | Andy Chan MD | Stephen Ho MD | Alison Harris MBChB |
LL-GIS-MO7B |
Increasing Uniformity of Ablation Zone in the Liver Using 3D Ultrasound Nirmal Kakani MD | Derek Cool MD, PhD | Aaron Fenster PhD | Hamid Reza Sadeghi Neshat MSc | Cesare Romagnoli MD | Rohit Joshi MD,BEng | Amol Mujoomdar MD |
LL-GIS-MO8A |
Quantification of Total Liver Fat Volume Using MRI-determined Proton Density Fat Fraction and Whole Liver Segmentation on MR at 3.0 T Claude Sirlin MD | Christopher Changchien BS | Arian Mashhood BS | Tanya Wolfson MS | Irene Cruite MD | Takeshi Yokoo MD, PhD | Michael Middleton PhD, MD | Gavin Hamilton PhD | Mark Bydder PhD | Michael Schroeder BS | Yauk Lee MD | Emmanuil Smorodinsky MD | Joshua Chen BS |
LL-GIS-MO8B |
Simultaneous Comparison of Gallbladder Ejection Fractions Measured by 3D Ultrasound and Cholescintigraphy John Knudsen MD | Matthew Callstrom MD, PhD | Grant Schmit MD | John Schmitz MD | Duane Meixner | Rickey Carter PhD | Douglas Collins MD |
LL-GIS-MO9A |
Reproducibility of MR Imaging-determined Proton Density Fat Fraction (PDFF) across Different MR Scanner Platforms Claude Sirlin MD | Geraldine Chang MD | Tanya Wolfson MS | Lisa Clark MPH, PhD | Michael Middleton PhD, MD | Gavin Hamilton PhD | Mark Bydder PhD | Anthony Gamst PhD |
LL-GIS-MO9B |
Agreement between MRI and MRS Fat Fraction Measurement in HIV Lipodystrophy-associated Fatty Liver Disease Claude Sirlin MD | Michael Middleton PhD, MD | Adrienne Schlang MD | Daniel Lee MD | Gavin Hamilton PhD |
Cite This Abstract